Skip to content

Centessa Pharmaceuticals PLC Sustainability Reports

Centessa Pharmaceuticals plc is a clinical-stage biotechnology company focused on discovering, developing, and delivering impactful medicines to patients. The company primarily leverages an asset-centric operational model to advance its portfolio, including orexin receptor 2 agonists for sleep disorders.

Sector: Manufacturing

Country: United Kingdom

Exchange: London Stock Exchange

LEI: 213800GIDAARDSKOI827

FIGI: BBG01081FC68

1 reports from 2022 to 2022